ATRI Atrion Corp

Price (delayed)

$465.25

Market cap

$818.82M

P/E Ratio

43.77

Dividend/share

$8.75

EPS

$10.63

Enterprise value

$811.68M

Atrion Corporation is a leading supplier of medical devices and components to niche markets in the health care and medical industry. Atrion's proprietary products, ranging from cardiovascular and ophthalmology products ...

Highlights
Atrion's quick ratio has increased by 33% YoY and by 23% from the previous quarter
ATRI's revenue is up by 4.3% since the previous quarter
ATRI's net income is down by 38% year-on-year and by 3.6% since the previous quarter
The EPS has decreased by 37% YoY and by 3.5% from the previous quarter

Key stats

What are the main financial stats of ATRI
Market
Shares outstanding
1.76M
Market cap
$818.82M
Enterprise value
$811.68M
Valuations
Price to book (P/B)
3.38
Price to sales (P/S)
4.63
EV/EBIT
37.36
EV/EBITDA
21.78
EV/Sales
4.59
Earnings
Revenue
$176.67M
EBIT
$21.73M
EBITDA
$37.26M
Free cash flow
$9.23M
Per share
EPS
$10.63
Free cash flow per share
$5.24
Book value per share
$137.47
Revenue per share
$100.38
TBVPS
$140.83
Balance sheet
Total assets
$258.63M
Total liabilities
$16.7M
Debt
$0
Equity
$241.92M
Working capital
$100.26M
Liquidity
Debt to equity
0
Current ratio
9.18
Quick ratio
2.86
Net debt/EBITDA
-0.19
Margins
EBITDA margin
21.1%
Gross margin
33.8%
Net margin
10.6%
Operating margin
12%
Efficiency
Return on assets
7.1%
Return on equity
7.8%
Return on invested capital
9.2%
Return on capital employed
8.8%
Return on sales
12.3%
Dividend
Dividend yield
1.88%
DPS
$8.75
Payout ratio
82.3%

ATRI stock price

How has the Atrion stock price performed over time
Intraday
2.06%
1 week
4.47%
1 month
16.67%
1 year
-17.14%
YTD
22.83%
QTD
0.37%

Financial performance

How have Atrion's revenue and profit performed over time
Revenue
$176.67M
Gross profit
$59.66M
Operating income
$21.25M
Net income
$18.72M
Gross margin
33.8%
Net margin
10.6%
Atrion's net margin has decreased by 38% YoY and by 8% QoQ
ATRI's net income is down by 38% year-on-year and by 3.6% since the previous quarter
The operating margin has contracted by 38% YoY and by 10% from the previous quarter
Atrion's operating income has decreased by 37% YoY and by 6% from the previous quarter

Growth

What is Atrion's growth rate over time

Valuation

What is Atrion stock price valuation
P/E
43.77
P/B
3.38
P/S
4.63
EV/EBIT
37.36
EV/EBITDA
21.78
EV/Sales
4.59
The EPS has decreased by 37% YoY and by 3.5% from the previous quarter
The stock's P/E is 20% above its 5-year quarterly average of 36.4 and 17% above its last 4 quarters average of 37.3
The stock's price to book (P/B) is 28% less than its 5-year quarterly average of 4.7 but 2.4% more than its last 4 quarters average of 3.3
ATRI's P/S is 34% below its 5-year quarterly average of 7.0
ATRI's revenue is up by 4.3% since the previous quarter

Efficiency

How efficient is Atrion business performance
The ROIC has contracted by 39% YoY and by 3.2% from the previous quarter
The ROS has decreased by 37% YoY and by 8% from the previous quarter
ATRI's return on equity is down by 37% year-on-year and by 3.7% since the previous quarter
ATRI's return on assets is down by 37% year-on-year and by 4.1% since the previous quarter

Dividends

What is ATRI's dividend history
DPS
$8.75
Dividend yield
1.88%
Payout ratio
82.3%
Recent dividends

Financial health

How did Atrion financials performed over time
ATRI's current ratio is up by 38% year-on-year
Atrion's quick ratio has increased by 33% YoY and by 23% from the previous quarter
Atrion's debt is 100% lower than its equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.